Chair, CEO

Executive Vice President and Chief Financial Officer

France denies contact with Eli Lilly over reported $17.5 billion Abivax deal

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

Dow Jones Top Company Headlines at 11 AM ET: Paramount Plans Proxy Fight to Push Hostile Warner Bid | Meta ...

Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

Clinical Development Scientist

Eli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana. The Clinical Development Scientist is responsible for managing clinical supply and implementing training for global clinical programs, while collaborating cross-functionally to support clinical and scientific execution of Lilly Gene Therapy programs.

Clinical Development Scientist – Lilly Gene Therapy, Sensory

President & Chief Executive Officer

Chief Scientific Officer

Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge

Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030

This Eaton Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Lyell Immunopharma Shares Rise After HC Wainwright Upgrade

0.4285714328289032

Senior Director, Clinical Development- Cell Therapy

Lyell Immunopharma is a clinical-stage company focused on advancing next-generation CAR T-cell therapies for patients with solid tumors and hematologic malignancies. The Sr. Director, Clinical Development will provide clinical leadership and strategic direction for cell therapy programs, overseeing clinical trials and ensuring compliance with regulatory standards.

Senior Vice President, AbbVie and President, Global Allergan Aesthetics

U.S. Medical Aesthetics Market to hit US$ 19.34 billion by 2033, (CAGR of 12.6%)

Dermal Fillers Market Size, Share, Growth & Forecast (2025–2032) | Industry Trends & Future Outlook

Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence

From Bangkok to the World: Aura Bangkok Clinic Showcases International Standards in Aesthetic Care

0.2857142984867096

Senior Scientific Director, Clinical Development - Consumer Eye Care Product Development

AbbVie is a company focused on innovative medicines and solutions in various therapeutic areas including eye care. The Senior Scientific Director will lead the development of consumer eye care products, overseeing clinical trials and collaborating with cross-functional teams to ensure high-quality data supports product strategies.

Chief Financial Officer

Vice President and Chief Compliance Officer, Region US

Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials

Glenmark Pharma to launch Ropivacaine Hydrochloride Injection USP in US

New Drug Approvals and their Contract Manufacture, 2025 Edition: How Global Issues Affect Pharma Manufacturers

Global General Anesthesia Drugs Market To Reach $6.08 Billion By 2029 With A Growth Rate Of 3.9%

Senior Manager, Business Development, Cell & Gene Therapies

Fresenius Kabi USA is seeking a Senior Manager, Business Development for their Cell & Gene Therapies division. This role is pivotal in driving global sales and business development strategy by identifying strategic partnerships and initiatives in the rapidly advancing field of cell and gene therapies, while collaborating with cross-functional teams to foster innovation and growth.

0.8571428656578064

Sr. Director Clinical Development – Lilly Gene Therapy

Eli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana. The Sr. Director of Clinical Development will be responsible for the clinical and scientific execution of global clinical programs, ensuring timely planning and management of clinical studies while collaborating cross-functionally to support various clinical programs.

Sr. Director Clinical Development – Lilly Gene Therapy, Sensory

President & Chief Executive Officer, Board Member

Leads Biolabs and DNTH initiate trial of LBL-047 in SLE

Leads Biolabs And Dianthus Therapeutics Announce Initiation Of Phase 1 Trial Of LBL-047 (Dnth212) In Healthy Volunteers And Patients With Systemic Lupus Erythematosus

Leads Biolabs and Dianthus Therapeutics announce initiation of phase 1 trial of LBL-047 (DNTH212) in healthy volunteers and patients with systemic lupus erythematosus

Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)

Senior Director, Clinical Development Scientist

Dianthus Therapeutics, Inc. is developing innovative therapies for severe autoimmune diseases. The Senior Director, Clinical Development Scientist will lead scientific aspects of global Phase III trials, providing leadership in protocol development and regulatory strategy to drive the progress of a novel therapeutic asset.

Director / Senior Director, Clinical Development Scientist

Executive Vice President, Chief Medical Officer and Head of Development

Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform

Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Lilly's prospective cardiometabolic launches dominate list of drugs to watch in 2026: Clarivate

12 Health Care Stocks Moving In Thursday's Intraday Session

Senior Scientist, Analytical Development, Cell Therapy

Bristol Myers Squibb is a company that transforms the lives of patients through innovative work in various departments. They are seeking a highly motivated Senior Scientist to join their Cell Therapy Analytical Development department, where the role involves developing and troubleshooting LC-MS assays to advance gene-edited cell therapy development.

Dianthus Therapeutics is a clinical-stage biotechnology company focused on developing innovative monoclonal antibodies. The (Senior) Director, Clinical Development Scientist will lead scientific aspects of global Phase III trials, ensuring high-quality study design and execution while collaborating with internal and external teams.

Clinical Development Scientist – Lilly Gene Therapy, Sensory in united states (1000+)

Clinical Development Scientist – Lilly Gene Therapy, Sensory

Senior Director, Clinical Development- Cell Therapy

Senior Scientific Director, Clinical Development - Consumer Eye Care Product Development

Senior Manager, Business Development, Cell & Gene Therapies

Sr. Director Clinical Development – Lilly Gene Therapy, Sensory

Director / Senior Director, Clinical Development Scientist

Senior Scientist, Analytical Development, Cell Therapy

Director / Senior Director, Clinical Development Scientist